New Research Coverage Highlights BlackRock Capital

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
15
New Research Coverage Highlights BlackRock Capital Investment, Tootsie Roll Industries, Catalyst Biosciences, Macerich, Quotient Technology, and PennyMac Mortgage Investment Trust — Consolidated Revenues, Company Growth, and Expectations for 2018

NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BlackRock Capital Investment Corporation (NASDAQ: BKCC ), Tootsie Roll Industries, Inc. (NYSE: TR ), Catalyst Biosciences, Inc. (NASDAQ: CBIO ), Macerich Company (NYSE: MAC ), Quotient Technology Inc. (NYSE: QUOT ), and PennyMac Mortgage Investment Trust (NYSE: PMT ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BKCC DOWNLOAD: http://Fundamental-Markets.com/register/?so=BKCC TR DOWNLOAD: http://Fundamental-Markets.com/register/?so=TR CBIO DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBIO MAC DOWNLOAD: http://Fundamental-Markets.com/register/?so=MAC QUOT DOWNLOAD: http://Fundamental-Markets.com/register/?so=QUOT PMT DOWNLOAD: http://Fundamental-Markets.com/register/?so=PMT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine BlackRock Capital Investment Corporation (NASDAQ: BKCC ), Tootsie Roll Industries, Inc. (NYSE: TR ), Catalyst Biosciences, Inc. (NASDAQ: CBIO ), Macerich Company (NYSE: MAC ), Quotient Technology Inc. (NYSE: QUOT ), and PennyMac Mortgage Investment Trust (NYSE: PMT ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 21st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

BLACKROCK CAPITAL INVESTMENT CORPORATION (BKCC) REPORT OVERVIEW

BlackRock Capital Investment's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, BlackRock Capital Investment reported revenue of $20.84MM vs $24.93MM (down 16.41%) and basic earnings per share -$0.01 vs $0.20. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BlackRock Capital Investment reported revenue of $97.33MM vs $117.41MM (down 17.10%) and basic earnings per share $0.29 vs -$1.16. BlackRock Capital Investment is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $0.78 and is expected to report on March 6th, 2019.

To read the full BlackRock Capital Investment Corporation (BKCC) report, download it here: http://Fundamental-Markets.com/register/?so=BKCC

-----------------------------------------

TOOTSIE ROLL INDUSTRIES, INC. (TR) REPORT OVERVIEW

Tootsie Roll Industries' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Tootsie Roll Industries reported revenue of $101.80MM vs $104.46MM (down 2.54%) and basic earnings per share $0.13 vs $0.15 (down 13.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tootsie Roll Industries reported revenue of $519.29MM vs $521.10MM (down 0.35%) and basic earnings per share $1.24 vs $1.02 (up 21.91%). Tootsie Roll Industries is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018.

To read the full Tootsie Roll Industries, Inc. (TR) report, download it here: http://Fundamental-Markets.com/register/?so=TR

-----------------------------------------

CATALYST BIOSCIENCES, INC. (CBIO) REPORT OVERVIEW

Catalyst Biosciences' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Catalyst Biosciences reported revenue of $0.01MM vs $0.27MM (down 97.79%) and basic earnings per share -$0.56 vs -$4.57. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Catalyst Biosciences reported revenue of $1.02MM vs $0.40MM (up 155.14%) and basic earnings per share -$7.45 vs -$21.75. Catalyst Biosciences is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$2.53. The estimated EPS forecast for the next fiscal year is -$3.58 and is expected to report on March 7th, 2019.

To read the full Catalyst Biosciences, Inc. (CBIO) report, download it here: http://Fundamental-Markets.com/register/?so=CBIO

-----------------------------------------

MACERICH COMPANY (MAC) REPORT OVERVIEW

Macerich's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Macerich reported revenue of $236.73MM vs $247.05MM (down 4.17%) and basic earnings per share -$0.24 vs $0.48. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Macerich reported revenue of $993.66MM vs $1,041.27MM (down 4.57%) and basic earnings per share $1.02 vs $3.52 (down 71.02%). Macerich is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.98. The estimated EPS forecast for the next fiscal year is $4.14 and is expected to report on February 4th, 2019.

To read the full Macerich Company (MAC) report, download it here: http://Fundamental-Markets.com/register/?so=MAC

-----------------------------------------

QUOTIENT TECHNOLOGY INC. (QUOT) REPORT OVERVIEW

Quotient Technology's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Quotient Technology reported revenue of $86.77MM vs $72.58MM (up 19.55%) and basic earnings per share -$0.12 vs -$0.03. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Quotient Technology reported revenue of $322.12MM vs $275.19MM (up 17.05%) and basic earnings per share -$0.17 vs -$0.23. Quotient Technology is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is $0.35 and is expected to report on February 12th, 2019.

To read the full Quotient Technology Inc. (QUOT) report, download it here: http://Fundamental-Markets.com/register/?so=QUOT

-----------------------------------------

PENNYMAC MORTGAGE INVESTMENT TRUST (PMT) REPORT OVERVIEW

PennyMac Mortgage Investment Trust's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, PennyMac Mortgage Investment Trust reported revenue of $110.49MM vs $101.65MM (up 8.69%) and basic earnings per share $0.36 vs $0.42 (down 14.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, PennyMac Mortgage Investment Trust reported revenue of $469.31MM vs $421.86MM (up 11.25%) and basic earnings per share $1.53 vs $1.09 (up 40.37%). PennyMac Mortgage Investment Trust is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $1.74 and is expected to report on February 14th, 2019.

To read the full PennyMac Mortgage Investment Trust (PMT) report, download it here: http://Fundamental-Markets.com/register/?so=PMT

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com  

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 76

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 163

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 160

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 661

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 74

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 67

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 66

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 69

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 265

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Significant Information Regarding V.F. Corporation

Updated Category News Views 188

Understanding the Current Situation at V.F. Corporation V.F. Corporation, commonly referred to as VFC, is in the spotlight as claims are being investigated by legal teams representing investors. If you are among those impacted, it is essential to be well-informed and proactive in understanding your options. Losses Exceeding $50,000 - Know Your Rights If you have suffered...

Continue Reading
ImmunityBio Soars as Anktiva Fuels 700% Revenue Surge

Updated Category News Views 182

The Market's Wild Ride with ImmunityBio Talk about a rollercoaster! ImmunityBio Inc. is strutting its stuff—stock's up over 55% in just the past month! This kinda takes me back to the dot-com bust: exciting ventures, bold promises, and whoosh—away we fly! Honestly, you can’t ignore that hefty 700% revenue jump. And get this— their leading drug, Anktiva, is really...

Continue Reading
Understanding the Class Action Lawsuit Involving Elevance Health

Updated Category News Views 329

Investigating the Class Action Lawsuit Against Elevance Health Investors should be aware of the ongoing class action lawsuit involving Elevance Health, Inc. (NYSE: ELV). This lawsuit has been initiated to address significant concerns regarding false and misleading statements made by the company. The deadline for potential lead plaintiffs to participate is approaching, and...

Continue Reading
Sprott's Financial Performance for Q2 2025 Highlights Growth

Updated Category News Views 189

Sprott Inc. Financial Performance Report Sprott Inc. (NYSE/TSX: SII) has released its financial results for the second quarter of 2025. The company demonstrated significant growth with the total assets under management (AUM) rising to $40 billion by the end of June 2025. This marks a substantial 14% increase from $35.1 billion in the previous quarter and a compelling 27%...

Continue Reading
Analyzing Market Sentiment on Novo Nordisk Stocks

Updated Category News Views 239

Understanding Novo Nordisk's Stock Market Landscape Novo Nordisk has been experiencing notable fluctuations in its stock market sentiment. Recent reports indicate a decline in the company's short percent of float by 9.09%. With approximately 6.36 million shares sold short, this accounts for merely 0.2% of its available trading shares. Furthermore, based on the current...

Continue Reading